>

Kimberly White - Vertex Pharmaceuticals President

<div class='circular--portrait' style='background:#754DEB;color: white;font-size:3em;padding-top: 40px;;'>VRT</div>
VRTX -- USA Stock  

Fiscal Quarter End: March 31, 2020  

  President
Ms. Kimberly A. White is Senior Vice President and Chief Communications Officer of the Company. She spent the last seven years at Edelman, where she headed the agency global healthcare sector and led a team of 600 people worldwide. During her time at Edelman, Ms. White developed and implemented U.S. and global communications programs for a wide variety of companies and organizations in the healthcare industry. Before Edelman, she was the Chief Communications Officer at Baxter International Inc., where she led Baxter global communications function. Ms. White also spent more than 15 years with Ogilvy PR Worldwide, including as the CoManaging Director of the agency global healthcare practice. Ms. White will be responsible for leading the global corporate communications function, spanning product communications, media relations, digital and social communications, internal communications, corporate social responsibility and community affairs
  President Since 2018      
617 341-6100  www.vrtx.com
White most recently served as Global Chair of the Health Sector at Edelman.

Management Efficiency

The company currently holds 649.8 M in liabilities with Debt to Equity (D/E) ratio of 12.3 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Vertex Pharmaceuticals has Current Ratio of 3.37 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives

PRESIDENT Since

Glenn DavidZoetis
2016
Marion McCourtRegeneron Pharmaceuticals
2018
Alok SonigDr Reddys Laboratories Ltd
2015
Clinton LewisZoetis
2018
John WesolowskiPerrigo Company Plc
2016
George YancopoulosRegeneron Pharmaceuticals
2016
Christopher FenimoreRegeneron Pharmaceuticals
2017
Ganadhish KamatDr Reddys Laboratories Ltd
2016
Alejandro BernalZoetis
2015
Andrew FentonZoetis
2018
Roxanne LaganoZoetis
2015
Amit BiswasDr Reddys Laboratories Ltd
2016
James DillardPerrigo Company Plc
2019
Samiran DasDr Reddys Laboratories Ltd
2016
John HendricksonPerrigo Company Plc
2016
Jay MarkowitzRegeneron Pharmaceuticals
2017
Svend AndersenPerrigo Company Plc
2017
Michael AbermanRegeneron Pharmaceuticals
2015
Heidi ChenZoetis
2012
Grainne QuinnPerrigo Company Plc
2016
Joyce LeeZoetis
2012

Company Summary

Vertex Pharmaceuticals Incorporated engages in developing and commercializing therapies for the treatment of cystic fibrosis . The company was founded in 1989 and is headquartered in Boston, Massachusetts. Vertex Pharmaceuticals operates under Biotechnology classification in USA and is traded on BATS Exchange. It employs 3000 people.Vertex Pharmaceuticals Incorpor (VRTX) is traded on BATS Exchange in USA and employs 3,000 people.

Vertex Pharmaceuticals Leadership Team

William Young, Independent DirectorView
Reshma Kewalramani, Executive Vice President - Global Medicines Development and Medical Affairs and Chief Medical OfficerView
Michael Parini, Executive Vice President and Chief Legal OfficerView
Alan Garber, Independent DirectorView
Joshua Boger, Executive Director and Chairman of Science and Technology CommitteeView
John Gray, Senior Vice President Genetic TherapiesView
Margaret McGlynn, Independent DirectorView
Sangeeta Bhatia, DirectorView
Terrence Kearney, Independent DirectorView
Ian Smith, CFO, Executive Vice PresidentView
Paul Silva, Senior Vice President Corporate ControllerView
David Altshuler, Independent DirectorView
Jeffrey Chodakewitz, Chief Medical Officer and Senior Vice President - Global Medicines DevelopmentView
Elaine Ullian, Co-Lead Independent DirectorView
Amit Sachdev, Senior Vice President - Global Government Strategy, Market Access and ValueView
David Greenway, DirectorView
Charles Wagner, CFO, Executive Vice PresidentView
Bruce Sachs, Co-Lead Independent DirectorView
Lloyd Carney, Independent DirectorView
Michael Partridge, Vice President - Investor RelationsView
Yuchun Lee, Independent DirectorView
Kimberly White, Senior Vice President and Chief Communications OfficerView
Stuart Arbuckle, Chief Commercial Officer and Executive VPView
Thomas Graney, CFO, Senior Vice PresidentView
Charles Milstein, Executive Vice President Chief Legal and Administrative OfficerView
Jeffrey Leiden, Chairman of the Board and Presidentident, CEOView

Stock Performance Indicators

Did you try this?

Run Balance Of Power Now

   

Balance Of Power

Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
All  Next Launch Module

Also Currentnly Active

Purchased over 90 shares of
a day ago
Traded for 5.02
Purchased over 90 shares of
a day ago
Traded for 28.3
Purchased over 90 shares of
a day ago
Traded for 10.58
Also please take a look at World Market Map. Please also try Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of macroaxis ideas.